The purpose of this review was to estimate the extent of under-reporting of adverse drug
reactions (ADRs) to spontaneous reporting systems and to investigate whether there are …

The coronavirus disease (COVID-19) pandemic has affected an estimated 16 million persons
and caused 0.6 million deaths worldwide by September 2020. The pandemic has led to a …

Background Allopurinol is a urate-lowering therapy used to treat patients with gout.
Previous studies have shown that allopurinol has positive effects on several cardiovascular …

Background: A substantial number of women of childbearing age suffer from schizophrenia
and other mental illnesses that require the use of antipsychotic drugs. Atypical antipsychotics …

2 Introduction organisations, academia, pharmacy, general practice and clinical pharmacology,
and was chaired by Dr Patricia Wilkie, a lay member of the CSM. The first meeting was …

OBJECTIVE: Bupropion was developed for the treatment of depression, but subsequently was
found to be effective for smoking cessation. To date, there are no prospective comparative …

Background— Drug-induced long-QT syndrome (diLQTS) is an adverse drug effect that has
an important impact on drug use, development, and regulation. We tested the hypothesis …

Objectives The objective of this study was to determine the nature of evidence used to support
the withdrawal of marketing authorisations of drug products for safety reasons throughout …

The methods used for the evaluation of drug safety signals (including major signals leading
to withdrawal of products from the market) are inconsistent and sometimes of poor quality. …

Background: Mirtazapine is a novel piperazinoazepine antidepressant, unrelated to any
known class of antidepressants. Currently, apart from a few case reports and case series in the …